1. A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer. (December 2021) Authors: Yasuda, Hiroyuki; Ichihara, Eiki; Sakakibara-Konishi, Jun; Zenke, Yoshitaka; Takeuchi, Shinji; Morise, Masahiro; Hotta, Katsuyuki; Sato, Mineyoshi; Matsumoto, Shingo; Tanimoto, Azusa; Matsuzawa, Reiko; Kiura, Katuyuki; Takashima, Yuta; Yano, Seiji; Koyama, Junji; Fukushima, Takahiro; Hamamoto, Ju... Journal: Lung cancer Issue: Volume 162(2021) Page Start: 140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bronchoesophageal fistula formation after three courses of nivolumab for carcinoma of unknown primary with a subgroup of lung squamous cell carcinoma. Issue 12 (28th December 2020) Authors: Nishiyama, Akihiro; Sakaguchi, Hiroyuki; Yanagimura, Naohiro; Suzuki, Chiaki; Otani, Sakiko; Tanimoto, Azusa; Yamashita, Kaname; Takeuchi, Shinji; Ohtsubo, Koushiro; Ikeda, Hiroko; Yano, Seiji Journal: Oxford medical case reports Issue: Volume 2020:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cancer among children, adolescents and young adults in the Hokushin region, Japan, between 2010 and 2015. (16th November 2021) Authors: Okura, Eri; Nishino, Yoshikazu; Sakashita, Kazuo; Tanimoto, Azusa; Hayashi, Ryuji; Yoshida, Yoshio; Nakada, Mitsutoshi; Koizumi, Tomonobu; Yano, Seiji; Nakazawa, Yozo Journal: Japanese journal of clinical oncology Issue: Volume 52:Number 1(2022) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non–small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020‐02). Issue 10 (12th April 2022) Authors: Tanaka, Hisashi; Sakamoto, Hiroaki; Akita, Takahiro; Ohyanagi, Fumiyoshi; Kawashima, Yosuke; Tambo, Yuichi; Tanimoto, Azusa; Horiike, Atsushi; Miyauchi, Eisaku; Tsuchiya‐Kawano, Yuko; Yanagitani, Noriko; Nishio, Makoto Journal: Thoracic cancer Issue: Volume 13:Issue 10(2022) Page Start: 1471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor. Issue 9 (1st July 2013) Authors: Sakai, Kazuko; Horiike, Atsushi; Irwin, Darryl L.; Kudo, Keita; Fujita, Yoshihiko; Tanimoto, Azusa; Sakatani, Toshio; Saito, Ryota; Kaburaki, Kyohei; Yanagitani, Noriko; Ohyanagi, Fumiyoshi; Nishio, Makoto; Nishio, Kazuto Journal: Cancer science Issue: Volume 104:Issue 9(2013:Sep.) Page Start: 1198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Glycogen synthase kinase‐3 inhibition overcomes epithelial‐mesenchymal transition‐associated resistance to osimertinib in EGFR‐mutant lung cancer. Issue 7 (11th June 2020) Authors: Fukuda, Koji; Takeuchi, Shinji; Arai, Sachiko; Kita, Kenji; Tanimoto, Azusa; Nishiyama, Akihiro; Yano, Seiji Journal: Cancer science Issue: Volume 111:Issue 7(2020) Page Start: 2374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1‐rearranged tumor cells. Issue 7 (11th May 2022) Authors: Suzuki, Chiaki; Nishiyama, Akihiro; Arai, Sachiko; Tange, Shoichiro; Tajima, Atsushi; Tanimoto, Azusa; Fukuda, Koji; Takumi, Yohei; Kotani, Hiroshi; Takeuchi, Shinji; Yanagimura, Naohiro; Ohtsubo, Koushiro; Yamamoto, Norio; Omori, Koichi; Yano, Seiji Journal: Cancer science Issue: Volume 113:Issue 7(2022) Page Start: 2323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MET amplification results in heterogeneous responses to osimertinib in EGFR‐mutant lung cancer treated with erlotinib. Issue 10 (1st September 2020) Authors: Nishiyama, Akihiro; Takeuchi, Shinji; Adachi, Yuta; Otani, Sakiko; Tanimoto, Azusa; Sasaki, Motoko; Matsumoto, Shingo; Goto, Koichi; Yano, Seiji Journal: Cancer science Issue: Volume 111:Issue 10(2020) Page Start: 3813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Patient‐derived xenograft models of non‐small cell lung cancer for evaluating targeted drug sensitivity and resistance. Issue 10 (6th October 2019) Authors: Kita, Kenji; Fukuda, Koji; Takahashi, Hiro; Tanimoto, Azusa; Nishiyama, Akihiro; Arai, Sachiko; Takeuchi, Shinji; Yamashita, Kaname; Ohtsubo, Koshiro; Otani, Sakiko; Yanagimura, Naohiro; Suzuki, Chiaki; Ikeda, Hiroko; Tamura, Masaya; Matsumoto, Isao; Yano, Seiji Journal: Cancer science Issue: Volume 110:Issue 10(2019) Page Start: 3215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer. Issue 2 (6th January 2020) Authors: Takeuchi, Shinji; Hase, Tetsunari; Shimizu, Shinobu; Ando, Masahiko; Hata, Akito; Murakami, Haruyasu; Kawakami, Takahiro; Nagase, Katsuhiko; Yoshimura, Kenichi; Fujiwara, Tadami; Tanimoto, Azusa; Nishiyama, Akihiro; Arai, Sachiko; Fukuda, Koji; Katakami, Nobuyuki; Takahashi, Toshiaki; Hasegawa, Y... Journal: Cancer science Issue: Volume 111:Issue 2(2020) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗